Extract
Chronic breathlessness is a dominating symptom that restricts daily life for many people with cardiorespiratory disease [1]. Different dimensions of the symptom, such as the intensity, sensory qualities and emotional responses, can be assessed using the instruments Dyspnea-12 (D-12) [2] and the Multidimensional Dyspnea Profile (MDP) [3], which share similarities in the underlying constructs of what is measured [4] and have emerged as widely used instruments for multi-dimensional measurement of breathlessness.
Abstract
This paper reports minimal clinically important differences (MCIDs) for measuring different aspects of breathlessness using the instruments D-12 and MDP at long-term follow-up (6 months), which were similar to MCIDs at short-term (2 week) assessment https://bit.ly/36r8BnK
Acknowledgements
The authors thank research nurse Lisa Carlson, Dept Respiratory Medicine and Allergy, Karolinska University Hospital Solna, research nurse Karin Johansson, Dept of Cardiology, Örebro University Hospital, Helena Igelström, Dept of Neuroscience, Uppsala University, and all nurses and staff who were involved in conducting the study and caring for the patients.
Footnotes
Conflict of interest: M. Ekström has nothing to disclose.
Conflict of interest: H. Bornefalk has nothing to disclose.
Conflict of interest: C.M. Sköld has nothing to disclose.
Conflict of interest: C. Janson has nothing to disclose.
Conflict of interest: A. Blomberg has nothing to disclose.
Conflict of interest: J. Sandberg has nothing to disclose.
Conflict of interest: A. Bornefalk-Hermansson has nothing to disclose.
Conflict of interest: D.C. Currow is an unpaid advisory board member for Helsinn Pharmaceuticals, is a paid consultant and receives payment for intellectual property with Mayne Pharma, and is a consultant with Specialised Therapeutics Australia Pty. Ltd.
Conflict of interest: M.J. Johnson has nothing to disclose.
Conflict of interest: J. Sundh has nothing to disclose.
Support statement: The study was funded by unrestricted grants from the Swedish Respiratory Society, the Swedish Heart-Lung Foundation, the Swedish Society for Medical Research and the Swedish Research Council (Dnr: 2019-02081). Funding information for this article has been deposited with the Crossref Funder Registry.
- Received July 17, 2020.
- Accepted November 5, 2020.
- Copyright ©ERS 2021